blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2201963

EP2201963 - Glutamate modulating agents in the treatment of mental disorders [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  02.12.2016
Database last updated on 08.04.2026
Most recent event   Tooltip13.07.2018Lapse of the patent in a contracting state
New state(s): TR		published on 15.08.2018  [2018/33]
Applicant(s)For all designated states
Yale University
Office of Cooperative Research
433 Temple Street
New Haven, CT 06511 / US
[2016/04]
Former [2010/26]For all designated states
Yale University
Office of Cooperative Research, 433 Temple Street
New Haven, CT 06511 / US
Inventor(s)01 / Coric, Vladmir
7 Richborough Road
Madison, CT 06443 / US
02 / Krystal, John H.
119 Maple Vale Road
Woodbridge, CT 06525 / US
03 / Sanacora, Gerard
21 Arrowhead Drive
Guilford, CT 06437 / US
 [2016/04]
Former [2010/26]01 / Coric, Vladmir
7 Richborough Road
Madison, CT 06443 / US
02 / Krystal, John H.
119 Maple Vale Road
Woodbridge, CT 06525 / US
03 / Sanacora, Gerard
21 Arrowhead Drive
Guilford, CT 06437 / US
Representative(s)Tomkins & Co
5 Dartmouth Road
Dublin 6 / IE
[N/P]
Former [2016/04]Gates, Marie Christina Esther, et al
Tomkins & Co.
5 Dartmouth Road
Dublin 6 / IE
Former [2010/26]Gates, Marie Christina Esther, et al
Tomkins & Co. 5 Dartmouth Road
Dublin 6 / IE
Application number, filing date10156331.005.04.2006
[2010/26]
Priority number, dateUS20050668735P05.04.2005         Original published format: US 668735 P
US20050669774P07.04.2005         Original published format: US 669774 P
US20050690187P13.06.2005         Original published format: US 690187 P
US20050694621P27.06.2005         Original published format: US 694621 P
US20060756472P04.01.2006         Original published format: US 756472 P
[2010/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2201963
Date:30.06.2010
Language:EN
[2010/26]
Type: B1 Patent specification 
No.:EP2201963
Date:27.01.2016
Language:EN
[2016/04]
Search report(s)(Supplementary) European search report - dispatched on:EP17.05.2010
ClassificationIPC:A61K45/00, A61P25/00
[2010/26]
CPC:
A61K31/485 (EP,US); A61K31/13 (EP,US); A61K31/198 (EP,US);
A61K31/425 (EP,US); A61K31/428 (EP,US); A61K31/43 (EP,US);
A61K31/545 (EP,US); A61K45/06 (EP,US); A61P25/00 (EP);
G02B1/10 (US); G02B5/281 (US); G02B5/283 (US);
G02B5/285 (US); H10F39/024 (US); H10F39/8053 (US) (-)
C-Set:
A61K31/425, A61K2300/00 (EP,US)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/04]
Former [2010/26]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Glutamatmodulationsmittel bei der Behandlung mentaler Störungen[2010/26]
English:Glutamate modulating agents in the treatment of mental disorders[2010/26]
French:Agents de modulation du glutamate pour le traitement de troubles mentaux[2010/26]
Examination procedure12.03.2010Examination requested  [2010/26]
30.12.2010Amendment by applicant (claims and/or description)
01.03.2011Despatch of a communication from the examining division (Time limit: M04)
29.06.2011Reply to a communication from the examining division
09.07.2012Despatch of a communication from the examining division (Time limit: M06)
26.02.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
01.05.2013Reply to a communication from the examining division
20.03.2015Communication of intention to grant the patent
15.07.2015Fee for grant paid
15.07.2015Fee for publishing/printing paid
15.07.2015Receipt of the translation of the claim(s)
22.07.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
02.11.2015Communication of intention to grant the patent
18.11.2015Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP06749354.4  / EP1874353
Divisional application(s)EP15182562.7  / EP2982372
EP20189325.2
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20060749354) is  31.07.2008
Opposition(s)28.10.2016No opposition filed within time limit [2017/01]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
01.05.2013Request for further processing filed
01.05.2013Full payment received (date of receipt of payment)
Request granted
28.05.2013Decision despatched
Fees paidRenewal fee
12.03.2010Renewal fee patent year 03
12.03.2010Renewal fee patent year 04
12.03.2010Renewal fee patent year 05
25.04.2011Renewal fee patent year 06
25.04.2012Renewal fee patent year 07
29.04.2013Renewal fee patent year 08
28.04.2014Renewal fee patent year 09
27.04.2015Renewal fee patent year 10
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.04.2006
AT27.01.2016
CY27.01.2016
CZ27.01.2016
EE27.01.2016
LT27.01.2016
LV27.01.2016
PL27.01.2016
RO27.01.2016
SI27.01.2016
SK27.01.2016
TR27.01.2016
BG27.04.2016
GR28.04.2016
IS27.05.2016
PT27.05.2016
[2018/29]
Former [2018/28]HU05.04.2006
AT27.01.2016
CY27.01.2016
CZ27.01.2016
EE27.01.2016
LT27.01.2016
LV27.01.2016
PL27.01.2016
RO27.01.2016
SI27.01.2016
SK27.01.2016
BG27.04.2016
GR28.04.2016
IS27.05.2016
PT27.05.2016
Former [2017/15]AT27.01.2016
CZ27.01.2016
EE27.01.2016
LT27.01.2016
LV27.01.2016
PL27.01.2016
RO27.01.2016
SI27.01.2016
SK27.01.2016
BG27.04.2016
GR28.04.2016
IS27.05.2016
PT27.05.2016
Former [2016/50]AT27.01.2016
CZ27.01.2016
EE27.01.2016
LT27.01.2016
LV27.01.2016
PL27.01.2016
RO27.01.2016
SK27.01.2016
GR28.04.2016
IS27.05.2016
PT27.05.2016
Former [2016/49]AT27.01.2016
EE27.01.2016
LT27.01.2016
LV27.01.2016
PL27.01.2016
GR28.04.2016
IS27.05.2016
PT27.05.2016
Former [2016/39]AT27.01.2016
LT27.01.2016
LV27.01.2016
PL27.01.2016
GR28.04.2016
IS27.05.2016
PT27.05.2016
Former [2016/38]AT27.01.2016
LT27.01.2016
PL27.01.2016
GR28.04.2016
IS27.05.2016
PT27.05.2016
Former [2016/36]AT27.01.2016
LT27.01.2016
PL27.01.2016
GR28.04.2016
Former [2016/35]GR28.04.2016
Documents cited:Search[X] US6391922  (FOGEL BARRY S et al.)
 [X] WO0112184  (REVAAX PHARMACEUTICALS LLC et al.)
 [XD]   CORIC ET AL: "Benificial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive compulsive disorder and major depressive disorder.", PSYCHOPHARAMCOOGY, no. 167, 2003 - 2003, pages 219 - 220, XP002391358
 [X]   DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; December 2004 (2004-12-01), MATHEW SANJAY J ET AL: "Riluzole in generalized anxiety disorder: An open-label trial", XP002580707, Database accession no. PREV200510104929
 [X]   NEUROPSYCHOPHARMACOLOGY, vol. 29, no. Suppl. 1, December 2004 (2004-12-01), ANNUAL MEETING OF THE AMERICAN-COLLEGE-OF-NEUROPSYCHOPHARMACOLOGY; SAN JUAN, PR, USA; DECEMBER 12 -16, 2004, pages S154, ISSN: 0893-133X
Examination  DEAN ET AL, J. PSYCHIATRY NEUROSCI., vol. 36, 2011 - 2011, pages 78 - 86
   BERK ET AL, BIOL. PSYCHIATRY, vol. 64, 2008 - 2008, pages 468 - 475
   GRANT ET AL, ARCH. GEN PSYCHIATRY, vol. 66, 2009 - 2009, pages 756 - 763
   GRANT ET AL, BIOL. PSYHIATRY, vol. 62, 2007 - 2007, pages 652 - 657
   HUANG ET AL, J.NEUROSCI.RES, vol. 88, 1 June 2010 (2010-06-01) - 1 June 2010 (2010-06-01), pages 2618 - 2629
   REMINGTON ET AL, AM.J.ALZHEIMER'S DISEASE AND OTHER DEMENTIAS, vol. 24, no. 1, 2009 - 2009, pages 27 - 33
   LAVOLE ET AL, NEUROPSYCHOPHARMACOLOGY, vol. 33, 2008 - 2008, pages 2187 - 2199
   BERK ET AL, BIOL. PSYCHIATRY, vol. 64, 2008 - 2008, pages 361 - 368
   BULUT ET AL, WORLY J. OF BIOLOGICAL PSYHIATRY, vol. 10, no. 4, 2009 - 2009, pages 626 - 628
by applicantUS5310897
 US6031094
 US6566401
   SAXENA ET AL., J. CLIN. PSYCHIATTY, vol. 57, 1996, pages 303 - 6
   MCDOUGLE ET AL., J. CLIN. PSYCHIATRY, vol. 56, 1995, pages 526 - 8
   "Diagnostic and Statistical Manual ofmental Disorders, 4th Ed.,", 2000, AMERICAN PSYCHIATRIC ASSOCIATION
   GOODMAN, ARCH. GEN. PSYCHIATRY, vol. 46, 1989, pages 1006 - 1011
   GREENE; WUTS: "Protective Groups in Organic Synthesis, 2d. Ed.", 1991, JOHN WILEY AND SONS
   FIESER; FIESER: "Fieser and Fieser's Reagents for Organic Synthesis", 1994, JOHN WILEY AND SONS
   PAQUETTE,: "Encyclopedia of Reagents for Organic Synthesis", 1995, JOHN WILEY AND SONS
   PITTENGER ET AL., THE JOURNAL OF THE AMERICAN SOCIETY FOR EXPERIMENTAL NEUROTHERAPEUTICS, vol. 3, 2006, pages 69 - 81
   CORIC ET AL., PSYCHOPHARMACOLOGY, vol. 167, 2003, pages 210 - 220
   CORIC, BIOLOGICAL PSYCHIATRY, vol. 58, 2005, pages 424 - 428
   THOMSON: "Physician's Desk Reference, 59th Ed,", 2005, pages: 744 - 746
   PITTENGER ET AL., THE JOURNAL OF TLZE AMERICAN SOCIETY FOR EXPERIMENTAL NEUROTHERAPEUTICS, vol. 3, 2006, pages 69 - 81
   ALS. ROTHSTEIN ET AL., NATURE, vol. 433, 2005, pages 73 - 77
   GUEORGUIEVA; KRYSTAL, ARCHIVES OF GENERAL PSYCHIATFY, vol. 61, 2004, pages 310 - 317
   BROWN; PRESCOTT: "Applied Mixed Models in Medicine", 1999, JOHN WILEY & SONS
   SANACORA ET AL., ANA J PSYCHIATSY, vol. 161, no. 11, 2004, pages 2132
   ZARATE ET AL., AM. J. PSYCH., vol. 161, 2004, pages 171 - 4
   ROSENBERG ET AL., J. AM. ACAD. CHILD ADOLESC. PSYCHIATFY, vol. 39, no. 9, 2000, pages 1096 - 103
   ROSENBERG ET AL., J. ARN. ACAD. CHILD ADOLESC. PSYCHIATRY, vol. 43, no. 9, 2004, pages 1146 - 53
   SEIBYL ET AL.: "Neurobiology of Mental Illness", 2001, OXFORD UNIV. PRESS, pages: 170 - 189
   SANACORA ET AL., ANN. N. Y ACAD. SCI., vol. 1003, 2003, pages 292 - 308
   SANACORA ET AL., ARCH. GEN. PSYCHIATRY, vol. 61, 2004, pages 705 - 713
   AUER ET AL., BIOL. PSYCHIATRY, vol. 47, no. 4, 2000, pages 305 - 13
   LEBON ET AL., J. NEUROSCI., vol. 22, no. 5, 2002, pages 1523 - 31
   SHEN ET AL., PROC. NATL ACAD. SCI. USA., vol. 96, no. 14, 1999, pages 8235 - 40
   FOA ET AL., J. CONSULT. CLIN. PSYCHOL., vol. 51, 1983, pages 287 - 297
   OVERBECK ET AL., J. CLIN. PSYCHIATRY, vol. 63, 2002, pages 1106 - 1112
   ABRAMOWITZ, J., CLIN. PSYCHOI., vol. 60, 2004, pages 1133 - 1141
   CHRISTENSEN ET AL., J. CLIN. PSYCHIATRY, vol. 52, no. 10, 1991, pages 415 - 7
   KING ET AL., J. AM. ACAD. CHILD ADOLESC. PSYCHIATRY, vol. 38, no. 12, 1995, pages 1470 - 1
   WALSH; MCDOUGLE, EXPERT OPIN. PHARMACOTHER., vol. 6, no. 6, 2005, pages 975 - 84
   STREINCHENWEIN ET AL., AM. J. PSYCHIATRY, vol. 152, 1995, pages 1192 - 1196
   CHRISTENSON ET AL., AM. J. PSYCHIATRY, vol. 148, 1991, pages 1566 - 1571
   STANLEY ET AL., J. CLIN. PSYCHIATRY, vol. 52, 1991, pages 282
   STANLEY ET AL., J. CLIN. PSYCHOPHARMACOL., vol. 17, no. 4, 1997, pages 278 - 83
   SWEDO ET AL., N. ENGL. J. MED., vol. 321, no. 8, 1989, pages 497 - 501
   SWEDO ET AL., N ENGL. J. MED., vol. 329, no. 2, 1993, pages 141 - 2
   CORIC ET AL., PSYCHOPHARMACOLOGY, vol. 167, 2003, pages 219 - 220
   CORIC ET AL., BIOL. PSYCHIATRV, vol. 58, 2005, pages 424 - 428
   CORIC ET AL., BIOL. PSYCHIATRY, vol. 58, 2005, pages 424 - 428
   SASSO ET AL., J. CLIN. PSYCHOPHARMACOLO.
   PITTENGER ET AL., J. CLIN. PSYCHIATRY, vol. 66, no. 11, 2005, pages 1492 - 3
   ZARATE ET AL., BIOL. PSYCH., vol. 57, 2005, pages 430 - 432
   SANACORA ET AL., ANN. N.Y. ACAD. SCI., vol. 1003, 2003, pages 292 - 308
   SANACORA ET AL., AM. J. PSYCHIATRY, vol. 161, no. 11, 2004, pages 2132
   HASLER ET AL., PSYCHIATRY RES., vol. 135, no. 2, 2005, pages 121 - 32
   KEUTHEN ET AL., PSYCHOSOMATICS, vol. 42, no. 5, 2001, pages 397 - 403
   BURNS; RITTER, PHARMACOI. BIOCHENI. BEHAV., vol. 56, no. 1, 1997, pages 145 - 9
   ZENI ET AL., PHARMACOI. BIOCHEM. BEHAV., vol. 65, no. 1, 2000, pages 67 - 74
   GEORGESCU ET AL., J. NEUROSCI., vol. 25, no. 11, 2005, pages 2933 - 40
   DUVA ET AL., NEUROSCI. RES., vol. 52, no. 1, 2005, pages 95 - 106
   KISS, NEUROREPORT, vol. 8, no. 17, 1997, pages 3703 - 7
   VAN DEN POL, NEURON, vol. 40, no. 6, 2003, pages 1059 - 61
   MILLS ET AL., QJM., vol. 91, no. 7, 1998, pages 493 - 503
   MCELROY ET AL., AM. J. PSYCHIATRY, vol. 160, no. 2, 2003, pages 255 - 61
   DEBERNARDI ET AL., PROG. NEUROPSYCHOPHARMACOL. BIOL. PSYCHIATRY, vol. 29, no. 2, 2005, pages 339 - 41
   CNS DRUGS, vol. 15, no. 5, 2001, pages 351 - 9
   SIMEON ET AL., J. CLIN. PSYCHIATRY, vol. 58, no. 8, 1997, pages 341 - 7
   BLOCH ET AL., PSYCHOSOMATICS, vol. 42, no. 4, 2001, pages 314 - 9
   OLDS; MILNER, J. COMP. PHYSIOL. PSYCHOL., vol. 47, no. 6, 1954, pages 419 - 27
   NEUROSCIENCE, vol. 76, no. 4, 1997, pages 1105 - 12
   PATERSON ET AL., PSYCHOPHARMACOLOGY (BERL), vol. 167, no. 3, 2003, pages 257 - 64
   XI; STEIN, PSYCHOPHARMACOLOGY (BERL), vol. 164, no. 2, 2002, pages 144 - 50
   FIRST ET AL.: "Structured clinical interview for DSM-IV Axis I Disorders", 1997, AMERICAN PSYCHIATRIC PRESS, INC.
   CORIC ET AL., BIOL. PSYCHIATFY, vol. 58, 2005, pages 424 - 428
   JOEL, PROG NEUROPSYCHOPHARMACOL BIOL PSYCHIATJY, 2006
   MOGHADDAM ET AL., J. NEUROSCI, vol. 17, 1997, pages 2921 - 7
   INT'L J. NEUROPSYCHOPHARMACOL., vol. 4, no. 2, 2001, pages 179 - 90
   NEUROPSYCHOPHARM., 2006
   NEUROLOGY, vol. 54, 2000, pages 142 - 87
   DELORME ET AL., NEUROREPORT, vol. 15, 2004, pages 699 - 702
   SANACORA ET AL., AM. J. PSYCHIATRY, vol. 161, 2004, pages 2132
   ZARATE ET AL., AM. J. PSYCHIATRY, vol. 161, 2004, pages 171 - 174
   ZARATE ET AL., BIOL. PSYCHIATRY, vol. 57, 2005, pages 430 - 432
   CORIC ET AL., BIOL. PSYCHIATLY, vol. 58, 2005, pages 424 - 428
   ROTHSTEIN ET AL., NATURE, vol. 433, 2005, pages 73 - 77
   BROWN, N ENGL. J. MED., vol. 352, 2005, pages 13
   CORIC ET AL., BIOL. PSYCHIATTY, vol. 58, 2005, pages 424 - 428
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.